Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

3.1K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
3.1K
Autoimmune Disorders01:29

Autoimmune Disorders

1.9K
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
1.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Diagnosis and Metabolic Management of Adult Refsum Disease: Guidance From the Medical and Scientific Committee of Global DARE (Defeat Adult Refsum Everywhere).

Journal of inherited metabolic disease·2026
Same author

Lipoprotein apheresis in the era of new lipid-lowering therapies.

European heart journal·2026
Same author

Pretreatment blood NfL indicates response to cellular therapies in cerebral adrenoleukodystrophy.

Communications medicine·2026
Same author

Natural History of Clinical Phenotypes and Their Biochemical Correlates in Adult X-Linked Adrenoleukodystrophy.

Journal of inherited metabolic disease·2026
Same author

Use of Brain MRI in Cerebral Adrenoleukodystrophy: International Recommendations for Screening, Monitoring, and Research.

Neurology·2026
Same author

Psychological Framing of Illness: Early Family Trauma and Diagnostic Delay in Adult-Onset Metachromatic Leukodystrophy.

Case reports in psychiatry·2025

Related Experiment Video

Updated: Feb 19, 2026

A Rapid, Simple, and Standardized Homogenization Method to Prepare Antigen/Adjuvant Emulsions for Inducing Experimental Autoimmune Encephalomyelitis
05:44

A Rapid, Simple, and Standardized Homogenization Method to Prepare Antigen/Adjuvant Emulsions for Inducing Experimental Autoimmune Encephalomyelitis

Published on: December 9, 2022

4.6K

Immunoadsorption for autoimmune encephalitis.

Cordula Fassbender1, Reinhard Klingel1, Wolfgang Köhler2

  • 1Apheresis Research Institute, Cologne, Germany.

Atherosclerosis. Supplements
|November 4, 2017
PubMed
Summary

Autoimmune encephalitis, an inflammatory brain disorder, is now treatable due to autoantibody discoveries. Immunotherapies, including selective immunoadsorption, offer effective treatment options for patients.

Keywords:
Autoimmune encephalitisNMDAR autoantibodyPlasma exchangeTryptophan immunoadsorption

More Related Videos

Overcoming Unresponsiveness in Experimental Autoimmune Encephalomyelitis EAE Resistant Mouse Strains by Adoptive Transfer and Antigenic Challenge
08:38

Overcoming Unresponsiveness in Experimental Autoimmune Encephalomyelitis EAE Resistant Mouse Strains by Adoptive Transfer and Antigenic Challenge

Published on: April 9, 2012

21.1K
Author Spotlight: Adjuvant Activity of Mycobacterium paratuberculosis in Enhancing the Immunogenicity of Autoantigens During Experimental Autoimmune Encephalomyelitis
06:57

Author Spotlight: Adjuvant Activity of Mycobacterium paratuberculosis in Enhancing the Immunogenicity of Autoantigens During Experimental Autoimmune Encephalomyelitis

Published on: May 12, 2023

3.0K

Related Experiment Videos

Last Updated: Feb 19, 2026

A Rapid, Simple, and Standardized Homogenization Method to Prepare Antigen/Adjuvant Emulsions for Inducing Experimental Autoimmune Encephalomyelitis
05:44

A Rapid, Simple, and Standardized Homogenization Method to Prepare Antigen/Adjuvant Emulsions for Inducing Experimental Autoimmune Encephalomyelitis

Published on: December 9, 2022

4.6K
Overcoming Unresponsiveness in Experimental Autoimmune Encephalomyelitis EAE Resistant Mouse Strains by Adoptive Transfer and Antigenic Challenge
08:38

Overcoming Unresponsiveness in Experimental Autoimmune Encephalomyelitis EAE Resistant Mouse Strains by Adoptive Transfer and Antigenic Challenge

Published on: April 9, 2012

21.1K
Author Spotlight: Adjuvant Activity of Mycobacterium paratuberculosis in Enhancing the Immunogenicity of Autoantigens During Experimental Autoimmune Encephalomyelitis
06:57

Author Spotlight: Adjuvant Activity of Mycobacterium paratuberculosis in Enhancing the Immunogenicity of Autoantigens During Experimental Autoimmune Encephalomyelitis

Published on: May 12, 2023

3.0K

Area of Science:

  • Neurology
  • Immunology
  • Neuroinflammation

Background:

  • Autoimmune encephalitis is a severe, inflammatory brain disorder.
  • The identification of autoantibodies in non-infectious encephalitis marked a significant advancement.
  • Understanding antibody type and titer is crucial for guiding immunotherapy.

Purpose of the Study:

  • To highlight the breakthrough in treating autoimmune encephalitis through autoantibody identification.
  • To emphasize the role of immunotherapies in managing this condition.
  • To present selective immunoadsorption as an effective therapeutic strategy.

Main Methods:

  • Correlation of autoantibody type and titer with clinical presentation and severity.
  • Administration of first-line immunotherapies including steroids, IVIg, plasma exchange, and immunoadsorption.
  • Utilizing selective immunoadsorption for rapid autoantibody elimination.

Main Results:

  • Autoantibody discovery transformed the treatment of previously untreatable encephalitis.
  • Immunotherapies have become essential for managing autoimmune encephalitis.
  • Selective immunoadsorption is a proven, effective component of multimodal immunotherapy.

Conclusions:

  • Autoimmune encephalitis management has advanced significantly with the understanding of autoantibodies.
  • Multimodal immunotherapy, including selective immunoadsorption, offers a pathophysiologically guided approach.
  • Selective immunoadsorption provides an effective method for rapid autoantibody removal in autoimmune encephalitis treatment.